Avita Medical Stock Buy Hold or Sell Recommendation
| RCEL Stock | USD 13.07 0.27 2.02% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Avita Medical is 'Strong Hold'. The recommendation algorithm takes into account all of Avita Medical's available fundamental, technical, and predictive indicators you will find on this site.
Check out Avita Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide. Note, we conduct extensive research on individual companies such as Avita and provide practical buy, sell, or hold advice based on investors' constraints. Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
Avita |
Execute Avita Medical Buy or Sell Advice
The Avita recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Avita Medical. Macroaxis does not own or have any residual interests in Avita Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Avita Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Solid | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Avita Medical Trading Alerts and Improvement Suggestions
| Avita Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 50.14 M. Net Loss for the year was (35.38 M) with profit before overhead, payroll, taxes, and interest of 28.38 M. | |
| Avita Medical currently holds about 84.17 M in cash with (38.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67. | |
| Avita Medical has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: AVITA Medical to Present at the Piper Sandler 36Annual Health |
Avita Medical Returns Distribution Density
The distribution of Avita Medical's historical returns is an attempt to chart the uncertainty of Avita Medical's future price movements. The chart of the probability distribution of Avita Medical daily returns describes the distribution of returns around its average expected value. We use Avita Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Avita Medical returns is essential to provide solid investment advice for Avita Medical.
| Mean Return | 0.55 | Value At Risk | -3.33 | Potential Upside | 4.89 | Standard Deviation | 2.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Avita Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Avita Stock Institutional Investors
| Shares | Wellington Management Company Llp | 2024-06-30 | 73.2 K | Bank Of New York Mellon Corp | 2024-06-30 | 72.7 K | Nuveen Asset Management, Llc | 2024-06-30 | 71.7 K | Charles Schwab Investment Management Inc | 2024-09-30 | 70.9 K | Jane Street Group Llc | 2024-06-30 | 67.4 K | D. E. Shaw & Co Lp | 2024-09-30 | 67.1 K | Ameriprise Financial Inc | 2024-06-30 | 43.7 K | Curi Rmb Capital | 2024-09-30 | 43 K | Bank Of America Corp | 2024-06-30 | 41 K | Blackrock Inc | 2024-06-30 | 1.8 M | Vanguard Group Inc | 2024-09-30 | 1.4 M |
Avita Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (19.2M) | 78.0M | 53.5M | (121.3M) | 4.0M | 4.2M | |
| Capital Expenditures | 1.3M | 854.9K | 847K | 663.9K | 1.4M | 1.5M | |
| Net Income | (24.6M) | (60.9M) | (42.0M) | (39.2M) | (35.4M) | (33.6M) | |
| End Period Cash Flow | (19.2M) | 107.0M | 73.8M | 26.7M | 22.1M | 13.5M | |
| Depreciation | 264.7K | 673.8K | 465K | 834.3K | 632K | 448.0K | |
| Change To Inventory | 68.7K | (678.1K) | (468K) | (545.0K) | (3.7M) | (3.5M) | |
| Investments | (1.3M) | (847K) | (1.2M) | (19.3M) | 1.6M | 1.7M | |
| Change To Netincome | 2.3M | 17.5M | 6.9M | 7.9M | 9.0M | 5.5M |
Avita Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Avita Medical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Avita Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Avita stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.33 | |
β | Beta against Dow Jones | 1.79 | |
σ | Overall volatility | 2.93 | |
Ir | Information ratio | 0.15 |
Avita Medical Volatility Alert
Avita Medical currently demonstrates below-average downside deviation. It has Information Ratio of 0.15 and Jensen Alpha of 0.33. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Avita Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Avita Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Avita Medical Fundamentals Vs Peers
Comparing Avita Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Avita Medical's direct or indirect competition across all of the common fundamentals between Avita Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Avita Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Avita Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Avita Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Avita Medical to competition |
| Fundamentals | Avita Medical | Peer Average |
| Return On Equity | -1.52 | -0.31 |
| Return On Asset | -0.45 | -0.14 |
| Profit Margin | (0.95) % | (1.27) % |
| Operating Margin | (0.71) % | (5.51) % |
| Current Valuation | 350.96 M | 16.62 B |
| Shares Outstanding | 26.22 M | 571.82 M |
| Shares Owned By Insiders | 0.90 % | 10.09 % |
| Shares Owned By Institutions | 23.49 % | 39.21 % |
| Number Of Shares Shorted | 1.19 M | 4.71 M |
| Price To Book | 28.60 X | 9.51 X |
| Price To Sales | 5.83 X | 11.42 X |
| Revenue | 50.14 M | 9.43 B |
| Gross Profit | 28.38 M | 27.38 B |
| EBITDA | (57.92 M) | 3.9 B |
| Net Income | (35.38 M) | 570.98 M |
| Cash And Equivalents | 84.17 M | 2.7 B |
| Cash Per Share | 0.67 X | 5.01 X |
| Total Debt | 62.58 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 9.64 X | 2.16 X |
| Book Value Per Share | 0.47 X | 1.93 K |
| Cash Flow From Operations | (38.01 M) | 971.22 M |
| Short Ratio | 18.05 X | 4.00 X |
| Earnings Per Share | (2.19) X | 3.12 X |
| Price To Earnings To Growth | (0.04) X | 4.89 X |
| Target Price | 25.89 | |
| Number Of Employees | 207 | 18.84 K |
| Beta | 1.54 | -0.15 |
| Market Capitalization | 349.74 M | 19.03 B |
| Total Asset | 111.64 M | 29.47 B |
| Retained Earnings | (297.97 M) | 9.33 B |
| Working Capital | 90.81 M | 1.48 B |
| Net Asset | 111.64 M |
Note: Acquisition by James Corbett of 350000 shares of Avita Medical at 12.64 subject to Rule 16b-3 [view details]
Avita Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Avita . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Avita Medical Buy or Sell Advice
When is the right time to buy or sell Avita Medical? Buying financial instruments such as Avita Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2023 | 2024 (projected) | Working Capital | 2.3M | 3.1M | Market Cap | 148.5M | 126.3M |
Use Investing Ideas to Build Portfolios
In addition to having Avita Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Silver Thematic Idea Now
Silver
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Avita Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 2.335 | Quarterly Revenue Growth 0.432 | Return On Assets (0.45) | Return On Equity (1.52) |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.